OC-1031: The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer. (November 2020) - Thiruthaneeswaran, N.; Bibby, B.A.S.; Pereira, R.; More, E.; Denley, H.; Henry, A.; Wylie, J.; Hoskin, P.; Bristow, R.; Choudhury, A.; West, C.